That was the evidence presented during a two-week trial which was the latest case involving allegations that the popular birth control pills Yaz and Yasmin can cause life-threatening blood-clots.
The huge verdict is among the latest developments in litigation involving thousands of lawsuits centering on dangerous side effects from Yaz and Yasmin in state and federal courts across the country.
Lawyers for the woman in the Chicago verdict, Mariola Zapalski, told jurors during a two-week trial in Cook County, Illinois that she suffered a severe stroke two just weeks after her doctor prescribed Yasmin for her as her method of birth control.
As a result of her stroke the 37-year-old woman suffered a permanent brain injury and is now under 24-hour-a-day medical chair while confined to a wheelchair.
Zapalski, originally from Poland and now of Elmwood Park in Cook County was prescribed the controversial birth control medication by a Chicago doctor, according to testimony at the trial.
After taking the medication for less than two weeks, she suffered a severe debilitating stroke that paralyzed her entire left side, resulting in the loss of use of her arm and leg, according to a statement by her attorneys. She also sustained profound and permanent brain injuries.
Bayer Pharmaceuticals, while not a defendant in the Chicago case, has paid out an enormous amount of money to settle Yaz and Yasmin blood-clotting lawsuits as indicated in a recent financial filing to shareholders:
“As of October 18, 2013, Bayer had reached agreements, without admission of liability, to settle the claims of approximately 7,660 claimants in the U.S. for a total amount of about US$1.575 billion. Bayer has only been settling claims in the U.S. for venous clot injuries (deep vein thrombosis or pulmonary embolism) after a case-specific analysis of medical records on a rolling basis. Such injuries are alleged by about 2,300 of the pending unsettled claimants. Bayer will continue to consider the option of settling such individual lawsuits in the U.S. on a case-by-case basis.”
Bayer also has agreed to pay up to $24 million to settle other lawsuits in a multi-district litigation involving allegations over gall bladder side effects, according to the court file in the litigation.